CATABASIS PHARMACEUTICALS IN's ticker is and the CUSIP is 14875P206. A total of 24 filers reported holding CATABASIS PHARMACEUTICALS IN in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $25,000 | +56.2% | 8,676 | +13.7% | 0.00% | – |
| Q4 2020 | $16,000 | -92.2% | 7,629 | -76.9% | 0.00% | – |
| Q3 2020 | $204,000 | -17.1% | 32,970 | -13.8% | 0.00% | – |
| Q2 2020 | $246,000 | +2136.4% | 38,266 | +2643.1% | 0.00% | – |
| Q2 2019 | $11,000 | +37.5% | 1,395 | +43.8% | 0.00% | – |
| Q1 2019 | $8,000 | -42.9% | 970 | -68.6% | 0.00% | – |
| Q4 2018 | $14,000 | – | 3,090 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 300,000 | $2,421,000 | 1.60% |
| SV Health Investors, LLC | 285,765 | $2,306,000 | 1.55% |
| Alyeska Investment Group, L.P. | 1,125,000 | $9,079,000 | 0.12% |
| FEDERATED HERMES, INC. | 2,189,400 | $17,668,000 | 0.04% |
| OXFORD ASSET MANAGEMENT LLP | 139,451 | $1,125,000 | 0.02% |
| OPPENHEIMER & CO INC | 68,706 | $554,000 | 0.02% |
| RMB Capital Management, LLC | 60,618 | $489,000 | 0.01% |
| Blackstone Inc. | 200,819 | $1,621,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 20,900 | $169,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 218,651 | $1,765,000 | 0.00% |